Sage Mountain Advisors LLC - IBERE PHARMACEUTICALS ownership

IBERE PHARMACEUTICALS's ticker is IBERU and the CUSIP is G46843127. A total of 35 filers reported holding IBERE PHARMACEUTICALS in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Sage Mountain Advisors LLC ownership history of IBERE PHARMACEUTICALS
ValueSharesWeighting
Q4 2022$131,604
-5.3%
13,200
-5.8%
0.03%
-18.9%
Q3 2022$139,000
-82.0%
14,020
-82.2%
0.04%
-73.0%
Q2 2022$774,000
-2.5%
78,930
-2.6%
0.14%
+10.5%
Q1 2022$794,000
-11.2%
81,060
-9.1%
0.12%
+15.9%
Q4 2021$894,000
-1.9%
89,180
-2.1%
0.11%
-18.3%
Q3 2021$911,000
-3.0%
91,100
-2.5%
0.13%
-15.5%
Q2 2021$939,000
+1.8%
93,4700.0%0.16%
-20.9%
Q1 2021$922,00093,4700.20%
Other shareholders
IBERE PHARMACEUTICALS shareholders Q2 2021
NameSharesValueWeighting ↓
Hartree Partners, LP 1,285,000$12,914,250,0003.01%
Wealthspring Capital LLC 277,192$2,786,0000.70%
BASSO CAPITAL MANAGEMENT, L.P. 135,404$1,361,0000.17%
Omni Partners US LLC 364,371$3,662,0000.16%
Sage Mountain Advisors LLC 93,470$939,0000.16%
Castle Creek Arbitrage, LLC 253,446$2,540,0000.14%
Shaolin Capital Management LLC 396,200$3,982,0000.12%
Context Capital Management, LLC 115,053$1,156,0000.11%
PERISCOPE CAPITAL INC. 250,000$2,512,0000.08%
Magnetar Financial LLC 803,400$8,074,0000.08%
View complete list of IBERE PHARMACEUTICALS shareholders